Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Albuterol · 3 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | NISOLDIPINE EXTENDED-RELEASE TABLETS, 40 MG |
| 2 | ACTIVE_COMPARATOR | Sular® Extended Release 40 mg tablets |
| Name | Type | Description |
|---|---|---|
| Albuterol Sulfate Extended-Release Tablets 8 mg | DRUG | 8mg, single dose fed |
| VoSpire® ER Tablets 8 mg | DRUG | 8mg, single dose fed |
| albuterol sulfate extended-release 8 mg tablets | DRUG | 8mg, single dose fasting |
| VoSpire™ ER 8 mg tablets | DRUG | 8mg, single dose fasting |
I. Inclusion Criteria: Subjects who met the following criteria were included in the study. 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential had a negative serum beta human chorionic gonadotropin (β-HCG) pregnancy test perfor...